Genomic Test Predicts Which Prostate Cancer Patients Benefit From Abiraterone Therapy
Genomic Test Predicts Which Prostate Cancer Patients Benefit From Abiraterone Therapy Clinical Lab Products
Онкология
🎗️Лента новостей
Онкология
Presidential Symposium Highlights in Small Cell Lung Cancer
Presidential Symposium Highlights in Small Cell Lung Cancer The ASCO Post
Онкология
Of Note in the Oncology Community: September/October 2026
Of Note in the Oncology Community: September/October 2026 The ASCO Post
Онкология
SHR-A2102 at ESMO 2026 Shows 47.2% Response Rate in Recurrent or Metastatic Cervical Cancer
SHR-A2102 at ESMO 2026 Shows 47.2% Response Rate in Recurrent or Metastatic Cervical Cancer Oncodaily
Онкология
NCCS Researchers and Clinicians Advance Cancer Care at ESMO 2026
NCCS Researchers and Clinicians Advance Cancer Care at ESMO 2026 Oncodaily
🎗️
Онкология
Выявлены уязвимости MSS-колоректального рака — News-Medical
Выявлены уязвимости MSS-колоректального рака — News-Medical UA.NEWS
🎗️
Онкология
В Волгограде развивают ядерную медицину для диагностики и лечения рака
В Волгограде развивают ядерную медицину для диагностики и лечения рака Волгоградская Правда
Онкология
JSKN033 at ESMO 2026: Shows 52.9% Response Rate in Pretreated Cervical Cancer
JSKN033 at ESMO 2026: Shows 52.9% Response Rate in Pretreated Cervical Cancer Oncodaily
Онкология
JSKN033 at ESMO 2026: Shows 52.9% Response Rate in Pretreated Cervical Cancer
JSKN033 at ESMO 2026: Shows 52.9% Response Rate in Pretreated Cervical Cancer Oncodaily
Онкология
AI breast cancer survival model could improve accuracy and personalize care
New University of Cincinnati Cancer Center research published in the Journal of Statistical Theory and Practice describes the potential for a more robust and accurate breast cancer survival model that combines statistical methods with a deep learning framework. The goal is to give physicians a better tool to make…
🎗️
Онкология
Вакцина против рака кожи снизила риск рецидива на 42%
Вакцина против рака кожи снизила риск рецидива на 42% Korrespondent.net
Онкология
Вакцина против рака кожи снизила риск рецидива на 42%
Вакцина против рака кожи снизила риск рецидива на 42% Korrespondent.net
Онкология
Study identifies potential new ways to treat the most common type of bowel cancer - News-Medical
Study identifies potential new ways to treat the most common type of bowel cancer News-Medical
Онкология
ИИ поможет дерматологам оценивать кожные поражения на риск рака
ИИ поможет дерматологам оценивать кожные поражения на риск рака Наука Mail